Solid Biosciences (SLDB) Current Assets (2017 - 2024)
Historic Current Assets for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $179.5 million.
- Solid Biosciences' Current Assets rose 2099.69% to $179.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $179.5 million, marking a year-over-year increase of 2099.69%. This contributed to the annual value of $129.7 million for FY2023, which is 4093.28% down from last year.
- Latest data reveals that Solid Biosciences reported Current Assets of $179.5 million as of Q3 2024, which was up 2099.69% from $197.6 million recorded in Q2 2024.
- Solid Biosciences' Current Assets' 5-year high stood at $274.3 million during Q1 2021, with a 5-year trough of $27.2 million in Q3 2020.
- In the last 5 years, Solid Biosciences' Current Assets had a median value of $179.5 million in 2024 and averaged $170.6 million.
- Its Current Assets has fluctuated over the past 5 years, first crashed by 7606.7% in 2020, then skyrocketed by 77920.62% in 2021.
- Solid Biosciences' Current Assets (Quarter) stood at $158.9 million in 2020, then skyrocketed by 40.09% to $222.6 million in 2021, then fell by 1.34% to $219.6 million in 2022, then tumbled by 40.93% to $129.7 million in 2023, then surged by 38.36% to $179.5 million in 2024.
- Its Current Assets stands at $179.5 million for Q3 2024, versus $197.6 million for Q2 2024 and $214.2 million for Q1 2024.